rs201099906
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001365999.1(SZT2):c.5906G>A(p.Arg1969Gln) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000496 in 1,614,050 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001365999.1 missense, splice_region
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 18Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
 - genetic developmental and epileptic encephalopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
 - undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| SZT2 | NM_001365999.1  | c.5906G>A | p.Arg1969Gln | missense_variant, splice_region_variant | Exon 42 of 72 | ENST00000634258.3 | NP_001352928.1 | |
| SZT2 | NM_015284.4  | c.5735G>A | p.Arg1912Gln | missense_variant, splice_region_variant | Exon 41 of 71 | NP_056099.3 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| SZT2 | ENST00000634258.3  | c.5906G>A | p.Arg1969Gln | missense_variant, splice_region_variant | Exon 42 of 72 | 5 | NM_001365999.1 | ENSP00000489255.1 | ||
| SZT2 | ENST00000562955.2  | c.5735G>A | p.Arg1912Gln | missense_variant, splice_region_variant | Exon 41 of 71 | 5 | ENSP00000457168.1 | |||
| SZT2 | ENST00000648058.1  | n.2360G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 10 of 40 | ||||||
| SZT2 | ENST00000649403.1  | n.656G>A | splice_region_variant, non_coding_transcript_exon_variant | Exon 7 of 37 | 
Frequencies
GnomAD3 genomes   AF:  0.0000460  AC: 7AN: 152194Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.0000478  AC: 12AN: 251230 AF XY:  0.0000442   show subpopulations 
GnomAD4 exome  AF:  0.0000499  AC: 73AN: 1461738Hom.:  0  Cov.: 30 AF XY:  0.0000454  AC XY: 33AN XY: 727160 show subpopulations 
Age Distribution
GnomAD4 genome   AF:  0.0000460  AC: 7AN: 152312Hom.:  0  Cov.: 32 AF XY:  0.00  AC XY: 0AN XY: 74472 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
Developmental and epileptic encephalopathy, 18    Uncertain:2 
- -
- -
not provided    Uncertain:2 
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 1912 of the SZT2 protein (p.Arg1912Gln). This variant is present in population databases (rs201099906, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with SZT2-related conditions. ClinVar contains an entry for this variant (Variation ID: 411948). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at